GeminIQ Website Logo

Viewing TLRY free

Subscribe for full history, 50+ metrics, screener, watchlist...

Tilray Brands, Inc.

TLRY

Companies in Medicinal Chemicals & Botanical Products

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-02-28
2025-11-30
2025-08-31
2025-05-31
2025-02-28
2024-11-30
2024-08-31
2024-05-31
2024-02-29
2023-11-30
2023-08-31
2023-05-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets Current
Cash And Cash Equivalents At Carrying Value
205247265222-190205228146143178207
Restricted Cash Current
---------22-
Restricted Cash And Cash Equivalents At Carrying V…
45-----------
Marketable Securities Current
1545035-63753280116287242
Accounts Receivable Net Current
118109107121-11310410290918286
Inventory Net
292283283271263266264252244253232201
Prepaid Expense And Other Assets Current
41414134-45453143374538
Land Available For Sale
--------2914-
Assets Held For Sale Not Part Of Disposal Group Cu…
2466-313332---0
Assets Current
719729701689-707726678631642829773
Property Plant And Equipment And Finance Lease Rig…
543550560568538554555558579615495430
Operating Lease Right Of Use Asset
1820212217181716171466
Crypto Asset Fair Value Noncurrent
111---------
Intangible Assets Net Excluding Goodwill
23222521847867909915930953968974
Goodwill
7527527527521,3002,0012,0102,0092,0102,0102,0102,009
Other Long Term Investments
-131010-7888888
Equity Method Investments
-------00555
Notes And Loans Receivable Net Noncurrent
---00323232327575103
Long Term Investments
8-----------
Other Assets Noncurrent
11111211-5556990
Assets
2,0752,0992,0832,074-4,1924,2624,2224,2134,3314,4024,307
Liabilities Current
Short Term Borrowings
9987-18181815201523
Accounts Payable And Accrued Liabilities Current
224226231235217222236242210217238191
Business Combination Contingent Consideration Liab…
00015-15151508716
Derivative Liabilities Current
0051-23334102
Secured Debt Current
17171615-16161612131324
Convertible Debt Current
---0000083128252174
Liabilities Current
258259268280-279294299329395537433
Liabilities Noncurrent
Business Combination Contingent Consideration Liab…
-------014131311
Secured Long Term Debt
135139144148-149155158166169152137
Convertible Debt Noncurrent
88868486104123133130127124121221
Deferred Income Tax Liabilities Net
8624-126136131161166170167
Other Liabilities Noncurrent
0011-0000000
Liabilities
549552562585-7387787788709371,001977
Stockholders Equity
Common Stock Value
0000-0000000
Treasury Stock Common Value
0000-0-0----
Preferred Stock Value
0000-0000000
Additional Paid In Capital Common Stock
6,5216,5116,4316,402-6,3066,2186,1476,0315,9435,9105,778
Accumulated Other Comprehensive Income Loss Net Of…
-44-39-43-43--48-40-43-43-38-44-47
Retained Earnings Accumulated Deficit
-4,919-4,892-4,848-4,847--2,785-2,700-2,660-2,629-2,536-2,487-2,416
Stockholders Equity
1,5571,5801,5411,4902,7023,4733,4783,4433,3593,3933,4023,316
Minority Interest
-32-33-20-22--1950-16252214
Liabilities And Stockholders Equity
2,0752,0992,0832,074-4,1924,2624,2224,2134,3314,4024,307
Common Stock Par Or Stated Value Per Share
0000-0000000
Common Stock Shares Authorized
1,4161,4161,4161,4161,4161,1981,1981,4161,1981,198980980
Common Stock Shares Issued
1171171121069893888377737266
Shares Outstanding
1,1651,0491,1181,061983929832832774733723657
Treasury Stock Common Shares
0032104-0----
Preferred Stock Par Or Stated Value Per Share
0000-0000000
Preferred Stock Shares Authorized
101010101010101010101010
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-36.19%-61.43%-54.29%-18.29%-13.80%-30.78%9.93%-13.84%-22.96%---
20253.14%-15.72%-10.06%-14.63%-39.84%-46.34%0.00%-6.52%-13.04%98.28%108.62%168.97%
2024-22.97%-18.92%-1.35%-10.90%-18.01%17.06%1.94%-12.62%-19.42%-3.98%-14.43%-20.90%
2023------1.09%-37.23%-43.07%36.79%51.81%4.15%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-02-28
2025-11-30
2025-08-31
2025-05-31
2025-02-28
2024-11-30
2024-08-31
2024-05-31
2024-02-29
2023-11-30
2023-08-31
2023-05-31
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.79
2.81
2.62
2.46
-
2.54
2.47
2.27
1.92
1.63
1.54
1.79
Quick Ratio
1.50
1.56
1.41
1.37
-
1.42
1.42
1.32
1.05
0.89
1.03
1.24
Working Capital
461.22M
470.00M
433.51M
408.32M
-
428.82M
432.33M
378.54M
302.11M
247.04M
291.98M
340.05M
Leverage & Debt
Debt to Equity
0.35
0.35
0.36
0.39
-
0.21
0.22
0.23
0.26
0.28
0.29
0.29
Interest Coverage TTM
-70.98
-91.10
-83.71
-76.21
-24.13
-4.99
-4.86
-4.80
-7.76
-55.97
-72.75
-100.81
Debt Ratio
0.26
0.26
0.27
0.28
-
0.18
0.18
0.18
0.21
0.22
0.23
0.23
Efficiency & Turnover
Asset Turnover TTM
0.41
0.27
0.26
0.26
-
0.19
0.19
0.19
0.17
0.14
0.13
0.13
Days Sales Outstanding TTM
50.34
48.34
46.38
49.59
-
44.75
41.83
43.47
41.22
46.97
50.59
52.82
Receivables Turnover TTM
7.25
7.55
7.87
7.36
-
8.16
8.73
8.40
8.85
7.77
7.21
6.91
Per Share Metrics
Diluted EPS TTM
-11.91
-19.09
-20.25
-24.50
-10.26
-2.86
-2.38
-3.30
-4.46
-19.53
-20.99
-23.51
Free Cash Flow Per Share TTM
-0.45
-0.45
-0.82
-1.43
-0.96
-1.06
-0.94
-0.81
-0.66
-0.61
0.24
-0.21
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
27.68%
28.02%
28.69%
29.29%
30.88%
30.47%
29.42%
28.31%
28.01%
20.99%
21.90%
23.43%
Operating Profit Margin TTM
-173.67%
-265.62%
-270.12%
-277.93%
-103.46%
-21.40%
-21.79%
-22.15%
-33.39%
-195.98%
-212.47%
-218.41%
Net Profit Margin TTM
-156.41%
-251.59%
-258.44%
-265.60%
-112.71%
-29.82%
-25.63%
-31.05%
-45.29%
-203.77%
-222.89%
-231.64%
Growth Metrics
Net Revenue Growth (1Y)
3.82%
0.98%
2.31%
4.10%
11.22%
18.38%
24.76%
25.80%
24.65%
16.26%
6.08%
-0.20%
Net Income Growth (1Y)
44.08%
751.96%
931.69%
790.42%
176.76%
-82.68%
-85.65%
-83.14%
-81.54%
144.03%
181.32%
204.67%
EPS Growth (1Y)
16.15%
567.85%
751.84%
642.73%
129.87%
-85.37%
-88.67%
-85.97%
-84.94%
104.27%
134.15%
137.24%
Valuation Metrics
P/E TTM
-0.66
-0.42
-0.68
-0.18
-0.72
-4.69
-7.19
-5.46
-3.88
-0.93
-1.41
-0.71
P/B TTM
0.57
0.57
0.95
0.26
0.25
0.33
0.43
0.39
0.39
0.39
0.60
0.31
P/S TTM
1.03
1.07
1.76
0.47
0.81
1.40
1.84
1.69
1.76
1.89
3.14
1.65
Market Cap
886.76M
893.78M
1.46B
382.84M
672.17M
1.16B
1.50B
1.34B
1.31B
1.32B
2.05B
1.03B
Enterprise Value
931.68M
897.53M
1.45B
418.04M
776.24M
1.27B
1.61B
1.43B
1.56B
1.63B
2.42B
1.41B
Calculated Values
Free Cash Flow TTM
-50.96M
-49.19M
-86.81M
-127.52M
-87.38M
-92.10M
-82.20M
-60.15M
-49.96M
-44.56M
16.38M
-12.89M
Net Debt
44.92M
3.75M
-11.91M
35.20M
104.07M
115.50M
116.94M
93.46M
256.71M
310.99M
375.41M
373.14M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-04-21Sale
Owner: Hopkinson, David G.
Title: -
Shares: 33,556
Price/Share: $6.94
Value: $232,878.64
Shares Owned: -
Relationship: Director
Ownership: Direct
2025-07-31Purchase
Owner: Gendel, Mitchell
Title: Global General Counsel
Shares: 6,000
Price/Share: $0.58
Value: $3,480.00
Shares Owned: 698,287
Relationship: Officer
Ownership: Direct
2025-07-30Purchase
Owner: Merton, Carl A
Title: Chief Financial Officer
Shares: 33,500
Price/Share: $0.60
Value: $20,100.00
Shares Owned: 798,069
Relationship: Officer
Ownership: Direct
2025-07-30Purchase
Owner: Simon, Irwin D
Title: President and CEO
Shares: 165,000
Price/Share: $0.61
Value: $100,650.00
Shares Owned: 3,941,633
Relationship: Officer
Ownership: Direct
2024-11-15Purchase
Owner: Merton, Carl A
Title: Chief Financial Officer
Shares: 26,000
Price/Share: $1.36
Value: $35,360.00
Shares Owned: 26,000
Relationship: Officer
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
9.18%
Inst. Shares: 10,340,703
Shares Outstanding: 112,675,734
2025-12-31
9.76%
Inst. Shares: 10,770,688
Shares Outstanding: 110,343,368
2025-09-30
12.46%
Inst. Shares: 13,214,929
Shares Outstanding: 106,027,190
2025-06-30
13.87%
Inst. Shares: 12,347,010
Shares Outstanding: 89,032,602
2025-03-31
12.01%
Inst. Shares: 10,913,583
Shares Outstanding: 90,834,279

Tilray Brands, Inc. (TLRY) — SEC Financial Statements & Analysis

Tilray Brands, Inc. (TLRY) is a medicinal chemicals & botanical products company. Tilray Brands, Inc. trades on TLRY: Nasdaq as: TLRY. Based on its latest SEC filing (Form 10-Q, period ending 2026-02-28), Tilray Brands, Inc. reported a 3.82% year-over-year revenue growth, a Gross Profit Margin of 27.68% (TTM), a Debt-to-Equity ratio of 0.35x, a Price-to-Sales (P/S) ratio of 1.03x (TTM), a Price-to-Book (P/B) ratio of 0.57 (TTM), at a market cap of $886.76M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
3.82%
Gross Profit Margin TTM
27.68%
Debt To Equity
0.35x
P/S TTM
1.03x
P/B TTM
0.57
Market Cap
$886.76M

Data as of 2026-02-28 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Tilray Brands, Inc. in?

Tilray Brands, Inc. (TLRY) operates in the Medicinal Chemicals & Botanical Products industry.

What is TLRY's market cap?

Tilray Brands, Inc. (TLRY) has a market capitalization of $886.76M as of 2026-02-28.

What exchange does TLRY trade on?

Tilray Brands, Inc. (TLRY) trades on the TLRY: Nasdaq.

Research Faster.
Invest Smarter.

Tilray Brands, Inc. (TLRY) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.